Shanghai-based Ark licenses Roche IPF therapy

Ark Biosciences Inc. (Shanghai, China) gained exclusive, worldwide rights from Roche

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE